Placenta ingestion by rats enhances δ- and κ-opioid antinociception, but suppresses μ-opioid antinociception

Brain Research

Volumn 1014, Issue 1-2, 2004, Pages 22-33

  DiPirro, Jean M ^a,b   Kristal, Mark B ^a  

^a UNIVERSITY AT BUFFALO   (United States)

^b BUFFALO STATE COLLEGE   (United States)

Author keywords

Antinociception; DAMGO; DPDPE; Neurotransmitters, modulators, transporters and receptors; Opioid; Opioid receptor; Opioid receptors; Parturition; Placentophagia; POEF; Rat; Spiradoline

Indexed keywords

ANTINOCICEPTIVE AGENT; DELTA OPIATE RECEPTOR; DELTA OPIATE RECEPTOR AGONIST; ENKEPHALIN[2 DEXTRO ALANINE 4 METHYLPHENYLALANINE 5 GLYCINE]; ENKEPHALIN[2,5 DEXTRO PENICILLAMINE]; KAPPA OPIATE RECEPTOR; KAPPA OPIATE RECEPTOR AGONIST; MU OPIATE RECEPTOR; MU OPIATE RECEPTOR AGONIST; PLACENTA OPIOID ENHANCING FACTOR; SPIRADOLINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTINOCICEPTION; ARTICLE; CHILDBIRTH; CONTROLLED STUDY; DRUG ACTIVITY; DRUG MECHANISM; DRUG SPECIFICITY; EXPERIMENT; FEMALE; INGESTION; INJECTION; MEASUREMENT; NONHUMAN; PLACENTA; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN FUNCTION; RAT; TEMPERATURE;

ANALGESICS; ANIMALS; BEHAVIOR, ANIMAL; DIFFERENTIAL THRESHOLD; DOSE-RESPONSE RELATIONSHIP, DRUG; FEEDING BEHAVIOR; FEMALE; INJECTIONS, INTRAVENTRICULAR; MOTOR ACTIVITY; PAIN THRESHOLD; PLACENTA; PREGNANCY; PYRROLIDINES; RATS; RATS, LONG-EVANS; REACTION TIME; RECEPTORS, OPIOID, DELTA; RECEPTORS, OPIOID, KAPPA; RECEPTORS, OPIOID, MU; SEXUAL BEHAVIOR, ANIMAL;

EID: 2942709515     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2004.04.006     Document Type: Article

References (99)

1. Abbott P., Thompson A.C., Ferguson E.J., Doerr J.C., Tarapacki J.A., Kostyniak P.J., Syracuse J.A., Cartonia D.M., Kristal M.B. Placental opioid-enhancing factor (POEF): generalizability of effects. Physiol. Behav. 50:1991;933-940
2. Adams J.U., Bussiere J.L., Geller E.B., Adler M.W. Pyrogenic doses of intracerebroventricular interleukin-1 did not induce analgesia in the rat hot-plate or cold-water tail-flick tests. Life Sci. 53:1993;1401-1409
3. Adams J.U., Tallarida R.J., Geller E.B., Adler M.W. Isobolographic superadditivity between delta and mu opioid agonists in the rat depends on the ratio of compounds, the mu agonists and the analgesic assay used. J. Pharmacol. Exp. Ther. 266:1993;1261-1267
4. Adams J.U., Chen X., DeRiel J.K., Adler M.W., Liu-Chen L.-Y. Intracerebroventricular treatment with antisense oligodeoxynucleotide to κ-opioid receptors inhibited κ-agonist-induced analgesia in rats. Brain Res. 667:1994;129-132
5. Adler M.W., Geller E.B. Physiological functions of opioids: temperature regulation. Herz A., Akil H., Simon E.J. Handbook of Experimental Pharmacology: Opioids I. vol. 104:1993;205-238 Springer-Verlag, Berlin
6. Bodnar R.J., Williams C.L., Lee S.J., Pasternak G.W. Role of μ1-opiate receptors in supraspinal opiate analgesia: a microinjection study. Brain Res. 447:1988;25-34
7. Bridges R.S., Ronsheim P.M. Immunoreactive beta-endorphin concentrations in brain and plasma during pregnancy in rats: possible modulation by progesterone and estradiol. Neuroendocrinology. 45:1987;381-388
8. Briggs S.L., Rech R.H., Sawyer D.C. Kappa antinociceptive activity of spiradoline in the cold-water tail-flick assay in rats. Pharmacol. Biochem. Behav. 60:1998;467-472
9. Calcagnetti D.J., Holtzman S.G. Delta opioid antagonist, naltrindole, selectively blocks analgesia induced by DPDPE but not DAGO or morphine. Pharmacol. Biochem. Behav. 38:1991;185-190
10. Calenco-Choukroun G., Dauge V., Gacel G., Feger J., Roques B.P. Opioid δ agonists and endogenous enkephalins induce different emotional reactivity than μ agonists after injection in the rat ventral tegmental area. Psychopharmacology. 103:1991;493-502
11. Cogan R., Spinnato J.A. Pain discomfort thresholds in late pregnancy. Pain. 27:1986;63-68
12. Corpening J.W., Doerr J.C., Kristal M.B. Ingested bovine amniotic fluid enhances morphine antinociception in rats. Physiol. Behav. 70:2000;15-18
13. Czlonkowski A., Millan M.J., Herz A. The selective kappa-opioid agonist, U-50, 488H, produces antinociception in the rat via a supraspinal action. Eur. J. Pharmacol. 142:1987;183-184
14. Dauge V., Rossignol P., Roques B.P. Blockade of dopamine receptors reverses the behavioral effects of endogenous enkephalins in the nucleus caudatus but not in the nucleus accumbens: differential involvement of δ and μ opioid receptors. Psychopharmacology. 99:1989;168-175
15. Dawson-Basoa M., Gintzler A.R. 17-β-Estradiol and progesterone modulate an intrinsic opioid analgesic system. Brain Res. 601:1993;241-245
16. Dawson-Basoa M., Gintzler A.R. Estrogen and progesterone activate spinal kappa-opiate receptor analgesic mechanisms. Pain. 64:1996;608-615
17. Dawson-Basoa M., Gintzler A.R. Involvement of spinal cord δ opiate receptors in the antinociception of gestation and its hormonal simulation. Brain Res. 757:1997;37-42
18. DiPirro J.M., Kristal M.B. Placenta ingestion facilitates locomotion and antinociception induced by activation of delta-opioid receptors in the rat. Abstr.-Soc. Neurosci. 23:1997;680
19. DiPirro J.M., Thompson A.C., Kristal M.B. Amniotic-fluid ingestion enhances the central analgesic effect of morphine. Brain Res. Bull. 26:1991;851-855
20. Doerr J.C., Kristal M.B. Amniotic-fluid ingestion enhances morphine analgesia during morphine tolerance and withdrawal in rats. Physiol. Behav. 50:1991;633-635
21. Dondi D., Maggi R., Panerai A.E., Piva F., Limonata P. Hypothalamic opiatergic tone during pregnancy, parturition and lactation in the rat. Neuroendocrinology. 53:1991;460-466
22. Gear R.W., Miakowski C., Gordon N.C., Paul S., Heller P.H., Levine J.D. Kappa-opioids produce significantly greater analgesia in women than in men. Nat. Med. 2:1996;1248-1250
23. Gintzler A.R. Endorphin-mediated increase in pain threshold during pregnancy. Science. 210:1980;193-195
24. Goldstein A. Binding selectivity profiles for ligands of multiple receptor types: focus on opioid receptors. Trends Pharmacol. Sci. 8:1987;456-459
25. Goldstein A., Naidu A. Multiple opioid receptors: ligand profiles and binding signatures. Mol. Pharmacol. 36:1989;265-272
26. Hammer R.P., Bridges R.S. Preoptic area opioids and opiate receptors increase during pregnancy and decrease during lactation. Brain Res. 420:1987;48-56
27. Hammond D.L., Stewart P.E., Littell L. Antinociception and delta-1 receptors in the rat spinal cord: studies with intrathecal 7- benzylidenenaltrexone. J. Pharmacol. Exp. Ther. 274:1995;1317-1324
28. Handa B.K., Lane A.C., Lord J.A.H., Morgan B.A., Rance M.J., Smith C.F.C. Analogues of beta-LPH61-64 possessing selective agonist activity at mu-opiate receptors. Eur. J. Pharmacol. 70:1981;531-540
29. Handler C.M., Geller E.B., Adler M.W. Effects of mu-, kappa-, and delta-selective opioid agonists on thermoregulation in the rat. Pharmacol. Biochem. Behav. 43:1992;1209-1216
30. Improta G., Broccardo M. Spinal antinociceptive effects of [D-Ala2]Deltorphin II, a novel and highly selective delta-opioid receptor agonist. Peptides. 13:1992;1123-1126
31. Iwasaki H., Collins J.G., Saito Y., Kerman-Hinds A. Naloxone-sensitive, pregnancy-induced changes in behavioral responses to colorectal distention: pregnancy-induced analgesia to visceral stimulation. Anesthesiology. 74:1991;927-933
32. James I.F., Goldstein A. Site-directed alkylation of multiple opioid receptors: I. Binding selectivity. Mol. Pharmacol. 25:1984;337-342
33. Jayaram A., Singh P., Carp H. SCH 32615, an enkephalinase inhibitor, enhances pregnancy-induced analgesia in mice. Anesth. Analg. 80:1995;944-948
34. Jenck F., Bozarth M., Wise R.A. Contraversive circling induced by ventral tegmental microinjections of morphine and [D-Pen2, D-Pen5]enkephalin. Brain Res. 450:1988;382-386
35. Kepler K.L., Kest B., Kiefel J.M., Cooper M.L., Bodnar R.J. Roles of gender, gonadectomy and estrous phase in the analgesic effects of intracerebroventricular morphine in rats. Pharmacol. Biochem. Behav. 34:1989;119-127
36. Kiefel J.M., Rossi G.C., Bodnar R.J. Medullary mu and delta opioid receptors modulate mesencephalic morphine analgesia in rats. Brain Res. 624:1993;151-160
37. Kosterlitz H.W. Opioid peptides and their receptors. Proc. R. Soc. Lond., B Biol. Sci. 225:1985;27-40
38. Kristal M.B. Placentophagia: a biobehavioral enigma (or De gustibus non disputandum est). Neurosci. Biobehav. Rev. 4:1980;141-150
39. Kristal M.B. Enhancement of opioid-mediated analgesia: a solution to the enigma of placentophagia. Neurosci. Biobehav. Rev. 15:1991;425-435
40. Kristal M.B., Whitney J.F., Peters L.C. Placenta on pups' skin accelerates onset of maternal behavior in nonpregnant rats. Anim. Behav. 29:1981;81-85
41. Kristal M.B., Thompson A.C., Abbott P. Ingestion of amniotic fluid enhances opiate analgesia in rats. Physiol. Behav. 38:1986;809-815
42. Kristal M.B., Thompson A.C., Heller S.B., Komisaruk B.R. Placenta ingestion enhances analgesia produced by vaginal/cervical stimulation in rats. Physiol. Behav. 36:1986;1017-1020
43. Kristal M.B., Abbott P., Thompson A.C. Dose-dependent enhancement of morphine-induced analgesia by ingestion of amniotic fluid and placenta. Pharmacol. Biochem. Behav. 31:1988;351-356
44. Kristal M.B., Tarapacki J.A., Barton D. Amniotic fluid ingestion enhances opioid-mediated but not nonopioid-mediated analgesia. Physiol. Behav. 47:1990;79-81
45. Kristal M.B., Thompson A.C., Abbott P., DiPirro J.M., Ferguson E.F., Doerr J.C. Amniotic-fluid ingestion by parturient rats enhances pregnancy-mediated analgesia. Life Sci. 46:1990;693-698
46. Lahti R.A., Mickelson M.M., McCall J.M., Von Voightlander P.F. [3H]U-69593 a highly selective ligand for the opioid kappa receptor. Eur. J. Pharmacol. 109:1985;281-284
47. Latimer L.G., Duffy P., Kalivas P.W. Mu opioid receptor involvement in enkephalin activation of dopamine neurons in the ventral tegmental area. J. Pharmacol. Exp. Ther. 241:1987;328-337
48. Maldonado R., Feger J., Fournie-Zaluski M.C., Roques B.P. Differences in physical dependence induced by selective μ or δ opioid agonists and by endogenous enkephalins protected by peptidase inhibitors. Brain Res. 520:1990;247-254
49. Mann P.E., Kinsley C.H., Bridges R.S. Opioid receptor-subtype involvement in maternal behavior in lactating rats. Neuroendocrinology. 53:1991;487-492
50. Mansour A., Fox C.A., Burke S., Meng F., Thompson R.C., Akil H., Watson S.J. Mu, delta, and kappa opioid receptor mRNA expression in the rat CNS: an in situ hybridization study. J. Comp. Neurol. 350:1994;412-438
51. Mansour A., Fox C.A., Akil H., Watson S.J. Opioid-receptor mRNA expression in the rat CNS: anatomical and functional implications. Trends Neurosci. 18:1995;22-29
52. Matthes H.W., Maldonado R., Simonin F., Valverde O., Slowe S., Kitchen I., Befort K., Dierich A., Le Meur M., Dolle P., Tzavara E., Hanoune J., Roques B.P., Kieffer B.L. Loss of morphine-induced analgesia, reward effect and withdrawal symptoms in mice lacking the mu-opioid-receptor gene. Nature. 383:1996;759-760
53. Medina V.M., Dawson-Basoa M.E., Gintzler A.R. 17-β-Estradiol and progesterone positively modulate spinal cord dynorphin: relevance to the analgesia of pregnancy. Neuroendocrinology. 58:1993;310-315
54. Meecham K.G., Boyle S.J., Hunter J.C., Hughes J. An in vitro profile of activity for the (+) and (-) enantiomers of spiradoline and PD117302. Eur. J. Pharmacol. 173:1989;151-157
55. Meyer M.E., Meyer M.E. Behavioral effects of μ-opioid peptide agonists DAMGO, DALDA, and PL017 on locomotor activities. Pharmacol. Biochem. Behav. 46:1993;391-395
56. Meyer M.E., Meyer M.E. Behavioral effects of opioid peptide agonists DAMGO, DPDPE, and DAKLI on locomotor activities. Pharmacol. Biochem. Behav. 45:1993;315-320
57. Miaskowski C., Taiwo Y.O., Levine J.D. κ- and δ-opioid agonists synergize to produce potent analgesia. Brain Res. 509:1990;165-168
58. Millan M.J. Kappa-opioid receptors and analgesia. Trends Pharmacol. Sci. 11:1990;70-76
59. Monroe P.J., Hawranko A.A., Smith D.L., Smith D.J. Biochemical and pharmacological characterization of multiple β-endorphinergic antinociceptive systems in the rat periaqueductal gray. J. Pharmacol. Exp. Ther. 276:1995;65-73
60. Mosberg H.I., Hurst R., Hruby V.J., Gee K., Yamamura H.I., Galigan J.J., Burks T.F. Bis-penicillamine enkephalins possess highly improved specificity toward delta opioid receptors. Proc. Natl. Acad. Sci. U. S. A. 80:1983;5871-5874
61. Ohno M., Yamamoto T.S., Ueki S. Analgesic and discriminative properties of U-62, 066E, the selective kappa-opioid receptor agonist, in the rat. Psychopharmacology. 106:1992;31-38
62. Ossipov M.H., Kovelowski C.J., Nichols M.L., Hruby V.J., Porreca F. Characterization of supraspinal antinociceptive actions of opioid delta agonists in the rat. Pain. 62:1995;287-293
63. Pan Z.Z., Tershner S.A., Fields H.L. Cellular mechanism for anti-analgesic action of agonists of the κ-opioid receptor. Nature. 389:1997;382-385
64. Pasternak G.W. Pharmacological mechanisms of opioid analgesics. Clin. Neuropharmacol. 16:1993;1-18
65. Pastoriza L.N., Morrow T.J., Casey K.L. Medial frontal cortex lesions selectively attenuate the hot plate response: possible nocifensive apraxia in the rat. Pain. 64:1996;11-17
66. Pelissier T., Paeile C., Soto-Moyano R., Saavedra H., Hernandez A. Analgesia produced by intrathecal administration of the kappa opioid agonist, U-50, 488H, on formalin-evoked cutaneous pain in the rat. Eur. J. Pharmacol. 190:1990;287-293
67. Pellegrino L.J., Pellegrino A.S., Cushman A.J. A Stereotaxic Atlas of the Rat Brain. 1979;Plenum, New York
68. Petraglia F., Baraldi M., Giarri G., Facchinetti F., Santi M., Volpe A., Genazzani A.R. Opioid peptides of the pituitary and hypothalamus: changes in pregnant and lactating rats. J. Endocrinol. 105:1985;239-245
69. Picker M.J., Negus S.S., Powell K.R. Differential cross-tolerance to mu and kappa opioid agonists in morphine-tolerant rats responding under a schedule of food presentation. Psychopharmacology. 103:1991;129-135
70. Piercey M.F., Einspaur F.J. Spinal analgesic actions of kappa receptor agonists, U-50, 488H and spiradoline (U-62066). J. Pharmacol. Exp. Ther. 251:1989;267-271
71. Pinheiro Machado F° L.C., Hurnik J.F., Burton J.H. The effect of amniotic fluid ingestion on the nociception of cows. Physiol. Behav. 62:1997;1339-1344
72. Robinson T.M., Abbott P., Kristal M.B. Blockade of digestion by famotidine pretreatment does not interfere with the opioid-enhancing effect of ingested amniotic fluid. Physiol. Behav. 57:1995;261-263
73. Robinson-Vanderwerf T.M., DiPirro J.M., Caggiula A.R., Kristal M.B. The analgesia-enhancing component of ingested amniotic fluid does not affect nicotine-induced antinociception in naltrexone-treated rats. Pharmacol. Biochem. Behav. 58:1997;147-151
74. Roques B.P., Noble F., Dauge V., Fournie-Zaluski M.-C., Beaumont A. Neutral endopeptidase 24.11: structure, inhibition, and experimental and clinical pharmacology. Pharmacol. Rev. 45:1993;87-146
75. Rossi G.C., Pasternak G.W., Bodnar R.J. μ and δ synergy between the periaqueductal gray and the rostro-ventral medulla. Brain Res. 665:1994;85-93
76. Rossi G.C., Su W., Levanthal L., Su H., Pasternak G.W. Antisense mapping DOR-1 in mice: further support for δ receptor subtypes. Brain Res. 753:1997;176-179
77. Rothman R.B., Holaday J.W., Porecca F. Allosteric coupling among opioid receptors: evidence for an opioid receptor complex. Herz A., Akil H., Simon E.J. Handbook of Experimental Pharmacology: Opioids I. vol. 104:1993;217-237 Springer-Verlag, Berlin
78. Sander H.W., Gintzler A.R. Spinal cord mediation of the opioid analgesia of pregnancy. Brain Res. 408:1987;389-393
79. Schriefer J.A. Diethylstilbesterol- and pregnancy-induced changes in rat neurointermediate lobe oxytocin, arginine vasopressin, methionine enkephalin and dynorphin. Neuroendocrinology. 54:1991;185-191
80. Siegel S., Castellan N.J. Jr. Nonparametric Statistics for the Behavioral Sciences. 1988;McGraw-Hill, New York
81. Smith A.S., Lee N.M. Opioid receptor interactions: local and nonlocal, symmetric and symmetric, physical and functional. Life Sci. 73:2003;1873-1893
82. Smith D.J., Perrotti J.M., Crisp T., Cabral M.E.Y., Long J.T., Scalzitti J.M. The mu receptor is responsible for descending pain inhibition originating in the periaqueductal gray region of the rat. Eur. J. Pharmacol. 156:1988;47-54
83. Sora I., Funada M., Uhl G.R. The μ-opioid receptor is necessary for [D-Pen2, D-Pen5]enkephalin-induced analgesia. Eur. J. Pharmacol. 324:1997;R1-R2
84. Sora I., Takahashi N., Funada M., Ujike H., Revay R.S., Donovan D.M., Miner L.L., Uhl G.R. Opiate receptor knockout mice define μ receptor roles in endogenous nociceptive responses and morphine-induced analgesia. Proc. Natl. Acad. Sci. U. S. A. 94:1997;1544-1549
85. Spencer R.L., Hruby V.J., Burks T.F. Body temperature response profiles for selective mu, delta and kappa opioid agonists in restrained and unrestrained rats. J. Pharmacol. Exp. Ther. 246:1988;92-101
86. Takemori A.E., Portoghese P.S. Evidence for the interaction of morphine with kappa and delta opioid receptors to induce analgesia in β-Funaltrexamine-treated mice. J. Pharmacol. Exp. Ther. 243:1987;91-94
87. Tarapacki J.A., Thompson A.C., Kristal M.B. Gastric vagotomy blocks opioid analgesia enhancement produced by placenta ingestion. Physiol. Behav. 52:1992;179-182
88. Tarapacki J.A., Piech M., Kristal M.B. Ingestion of amniotic fluid by postpartum rats enhances morphine analgesia without liability to maternal behavior. Physiol. Behav. 57:1995;209-212
89. Thompson A.C., Kristal M.B. Opioid stimulation in the ventral tegmental area stimulates maternal behavior in rats. Brain Res. 743:1996;184-201
90. Thompson A.C., DiPirro J.M., Dickerson C.D., Kristal M.B. Amniotic-fluid ingestion inhibits contralateral circling after unilateral morphine injection into the ventral tegmental area. Abstr.-Soc. Neurosci. 17:1991;1539
91. Tseng L.L., Tang R., Stackman R., Camara A., Fujimoto J.M. Brainstem sites differentially sensitive to beta-endorphin and morphine for analgesia and release of met-enkephalin in anesthetized rats. J. Pharmacol. Exp. Ther. 253:1990;930-937
92. Von Voigtlander P.F., Lewis R.A. Analgesic and mechanistic evaluation of spiradoline, a potent kappa opioid. J. Pharmacol. Exp. Ther. 246:1988;259-262
93. Von Voigtlander P.F., Lahti R.A., Ludens J.H. U-50, 488: a selective and structurally novel non-mu (kappa) opioid agonist. J. Pharmacol. Exp. Ther. 224:1983;7-12
94. Wang H.Q., Kampine J.P., Tseng L.F. Antisense oligodeoxynucleotides to delta-opioid receptor messenger RNA selectively blocks the antinociception induced by intracerebroventricularly administered delta-, but not mu-, epsilon-, or kappa-opioid receptor agonists in the mouse. Neuroscience. 7:1996;445-452
95. Wardlaw L.R., Frantz A.G. Brain beta-endorphin during pregnancy, parturition and the postpartum period. Endocrinology. 113:1983;1664-1668
96. Watkins L.R., Wiertelak E.P., Maier S.F. Kappa opiate receptors mediate tail-shock induced antinociception at spinal levels. Brain Res. 582:1992;1-9
97. Woolfe G., MacDonald A.D. The evaluation of analgesic action of pethidine hydrochloride (Demerol). J. Pharmacol. Exp. Ther. 80:1944;300-307
98. Xin L., Geller E.B., Adler M.W. Body temperature and analgesic effects of selective mu and kappa opioid receptors microdialyzed into rat brain. J. Pharmacol. Exp. Ther. 281:1997;499-507
99. Young G.A., Khazan N. Differential tolerance and cross-tolerance to repeated daily injections of mu and kappa agonists in the rat. Neuropharmacology. 23:1984;505-509